Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome.
Liao, Juan; Wu, Xiao-Chuan; Cheng, Qia; Li, Can-Lin; Yi, Zhu-Wen; Cao, Yan; Shuai, Lan-Jun.
Biomed Res Int
; 2017: 9429314, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28951877
Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
Increased urinary CD80 excretion and podocyturia in Fabry disease.
Minimal change disease in graft versus host disease: a podocyte response to the graft?
Urinary CD80 excretion increases in idiopathic minimal-change disease.
CD80 and suPAR: diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response.
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome.